Evidence map›Paper›PMID 28453519›Full record

ArticlePLoS genetics2017

Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation.

Ethiraj Ravindran, Hao Hu, Scott A Yuzwa, Luis R Hernandez-Miranda, Nadine Kraemer, Olaf Ninnemann, Luciana Musante, Eugen Boltshauser, Detlev Schindler, Angela Hübner and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Homozygous mutation inJournal of medical genetics · 2022
    Article
  5. Article
  6. Case report: Expanding the phenotype ofFrontiers in neurology · 2022
    Article
  7. Frontiers in molecular neuroscience · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. A chromosome 1q22 microdeletion includingMolecular cytogenetics · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 5 countries.

Ethiraj RavindranInstitute of Cell Biology and Neurobiology, Charité University Medicine Berlin, Berlin, Germany.
Hao HuMax Planck Institute for Molecular Genetics, Berlin, Germany.
Scott A YuzwaDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.
Luis R Hernandez-MirandaMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Nadine KraemerInstitute of Cell Biology and Neurobiology, Charité University Medicine Berlin, Berlin, Germany.ORCID 0000-0002-7002-5161
Olaf NinnemannInstitute of Cell Biology and Neurobiology, Charité University Medicine Berlin, Berlin, Germany.ORCID 0000-0003-4485-6444
Luciana MusanteMax Planck Institute for Molecular Genetics, Berlin, Germany.
Eugen BoltshauserDepartment of Pediatric Neurology, University Children's Hospital of Zurich, Zurich, Switzerland.
Detlev SchindlerDepartment of Human Genetics, University of Würzburg, Würzburg, Germany.
Angela HübnerPediatrics, University Hospital, Technical University Dresden, Dresden, Germany.
Hans-Christian ReineckerGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Hans-Hilger RopersMax Planck Institute for Molecular Genetics, Berlin, Germany.
Carmen BirchmeierMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-2041-8872
Freda D MillerDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.
Thomas F WienkerMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-4224-2193
Christoph HübnerDepartment of Pediatric Neurology, Charité University Medicine Berlin, Berlin, Germany.
Angela M KaindlInstitute of Cell Biology and Neurobiology, Charité University Medicine Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEMax Planck Institute for Molecular Genetics · DEMax Delbrück Center · DEUniversity of Toronto · CAGuangzhou Women and Children Medical Center · CNHarvard University · USTechnische Universität Dresden · DEUniversity Children's Hospital Zurich · CHUniversity of Würzburg · DE

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Innate Immune Defense Mechanisms in the IntestineR01AI113333 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI REINECKER, HANS-CHRISTIAN · 2014 to 2025
$5.7M
Antigen Recognition at Intestinal Epithelial InterphasesR01DK068181 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2005 to 2017
$5.2M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
NIAID NIH HHS R01 AI113333NICHD NIH HHS U54 HD090255NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK068181
6 · The paper itself

Abstract

Mid-hindbrain malformations can occur during embryogenesis through a disturbance of transient and localized gene expression patterns within these distinct brain structures. Rho guanine nucleotide exchange factor (ARHGEF) family members are key for controlling the spatiotemporal activation of Rho GTPase, to modulate cytoskeleton dynamics, cell division, and cell migration. We identified, by means of whole exome sequencing, a homozygous frameshift mutation in the ARHGEF2 as a cause of intellectual disability, a midbrain-hindbrain malformation, and mild microcephaly in a consanguineous pedigree of Kurdish-Turkish descent. We show that loss of ARHGEF2 perturbs progenitor cell differentiation and that this is associated with a shift of mitotic spindle plane orientation, putatively favoring more symmetric divisions. The ARHGEF2 mutation leads to reduction in the activation of the RhoA/ROCK/MLC pathway crucial for cell migration. We demonstrate that the human brain malformation is recapitulated in Arhgef2 mutant mice and identify an aberrant migration of distinct components of the precerebellar system as a pathomechanism underlying the midbrain-hindbrain phenotype. Our results highlight the crucial function of ARHGEF2 in human brain development and identify a mutation in ARHGEF2 as novel cause of a neurodevelopmental disorder.

Indexed as

AnimalsCell MovementCytoskeletonExomeFemaleFrameshift MutationHigh-Throughput Nucleotide SequencingHomozygoteHumansIntellectual DisabilityMagnetic Resonance ImagingMaleMesencephalonMicePedigreerhoA GTP-Binding ProteinARHGEF2 protein, humanrhoA GTP-Binding ProteinRho Guanine Nucleotide Exchange Factors

Identifiers

PMID28453519
PMCPMC5428974
OpenAlexW2610055642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.